Sign in Subscribe
Scientists

Sequence Diversity in Pneumococcal Capsular Genes Linked to Vaccine Efficacy

Strategic Insights

— 2 min read

Scientists at the National Institute for Public Health and the Environment in Bilthoven, Netherlands, have investigated the sequence diversity of pneumococcal capsular genes in serotypes 6A, 6B, 6C, 19A, and 19F. The study, published in Plos One, found significant genetic variation within these serotypes, with some subtypes having multiple base pair differences from the reference sequence. The research suggests that these variations may result in altered polysaccharides or increased capsular polysaccharide production, potentially reducing vaccine-induced immunity. The study's findings also indicate shifts in the occurrence of capsular subtypes within non-vaccine serotypes after the introduction of the 7-valent pneumococcal vaccine.

Key Takeaways:

  • The study found significant sequence diversity within the capsular genes of pneumococcal serogroup 6 and 19, with multiple subtypes identified.
  • The genetic background of serogroup 6 was closely related to the capsular subtypes, whereas this was less pronounced for serogroup 19.
  • The study suggested that these variations may result in altered polysaccharides or increased capsular polysaccharide production, potentially reducing vaccine-induced immunity.
  • The introduction of the 7-valent pneumococcal vaccine led to shifts in the occurrence of capsular subtypes within non-vaccine serotypes.
  • The researchers concluded that these changes may indicate that non-vaccine serotypes are filling the niche of the vaccine serotypes.
  • The study highlights the importance of monitoring pneumococcal capsular gene sequence diversity to inform vaccine development and policy.
  • The researchers used allele-specific PCRs and specific gene sequencing to identify capsular subtypes, revealing the presence of 6, 3, and a single capsular subtype in serotypes 6A, 6B, and 6C, respectively.
  • The serotype 19A and 19F isolates comprised 3 and 4 capsular subtypes, respectively.
  • The study's findings suggest that ongoing surveillance is essential to understand the impact of pneumococcal capsular gene sequence diversity on vaccine efficacy.

Statistics:

  • 25 serogroup 6 and 20 serogroup 19 isolates were sequenced to investigate the sequence diversity of capsular genes.
  • 184 serogroup 6 and 195 serogroup 19 isolates were tested using allele-specific PCRs and specific gene sequencing to identify capsular subtypes.
  • 6, 3, and a single capsular subtype were identified in serotypes 6A, 6B, and 6C, respectively.
  • 3 and 4 capsular subtypes were identified in serotype 19A and 19F isolates, respectively.
  • The study suggested that the genetic background of serogroup 6 was closely related to the capsular subtypes, with a mean of 4.5 base pair differences from the reference sequence.

Sources:

  • Elberse, K., et al. "Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19." Plos One, vol. 6, no. 9, 2011, p. e25018. doi: 10.1371/journal.pone.0025018
  • National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Perinatal Screening, Bilthoven, Netherlands.

Read more